The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
For full access to this article login to GEN Select now.
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
- Capturing and identifying circulating DNA could hold the key to rapid, minimally invasive, disease diagnostics—ultimately improving clinical decision making and outcomes. [oonal / Getty Images]
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.